The role of Septin6 Group in Murine and Human Hematopoiesis
Septin6 组在小鼠和人类造血中的作用
基本信息
- 批准号:10718515
- 负责人:
- 金额:$ 35.4万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-08-01 至 2026-05-31
- 项目状态:未结题
- 来源:
- 关键词:AdoptedAffectAgingAmino Acid Sequence HomologyAmino Acid SubstitutionAmino AcidsApoptosisAwarenessBloodBundlingC-terminalCD34 geneCSF3 geneCell CycleCell Differentiation processCell NucleusCell ProliferationCell divisionCell physiologyCellsClinicalCodon NucleotidesComplexCytokinesisDataDiffusionEngraftmentExocytosisExonsFilamentGTP Binding DomainGenesGerm-Line MutationGrowthGuanosine Triphosphate PhosphohydrolasesHematopoiesisHematopoieticHematopoietic stem cellsHomingHumanIn VitroIndividualLinkMammalian CellMarrowMicrofilamentsModelingMusMutationMyelogenousMyeloid CellsN-terminalNatureNeutropeniaNewborn InfantNucleotidesPathologicPathway interactionsPatientsPhenocopyPhenotypePlayProliferatingProlineProteinsPublicationsRefractoryRegulationReportingRoleStructureSyndromeTetraploidyVariantVesicleXenograft Modelcell motilitycombinatorialin silicoknock-downmalemembermutantnegative affectnovelpredictive modelingprogenitortrafficking
项目摘要
(PLEASE KEEP IN WORD, DO NOT PDF)
Title: The role of Septin6 Group in Murine and Human Hematopoiesis
1 R01 DK137172-01
Septins are highly conserved GTPase proteins which regulate a variety of cellular functions including cytokinesis, polarity, cell cycle, vesicle trafficking, exocytosis, and creation of diffusion barriers. We have recently identified a non-syndromic newborn with severe neutropenia (Renella, AJH 2022) with a novel X-linked germline mutation in the C-terminus of SEPTIN6 gene (SEPTIN6 c.1282T>C p.428Glnext*9) associated with dysmyelopoiesis. Editing the germline mutation into normal male CD34+ hematopoietic stem and progenitor cells (HSC/P) phenocopied key pathologic features of the clinical syndrome, including large, multinucleated nuclei and reduced myeloid progenitor growth in vitro (preliminary data). The C-terminus has been proposed to play a key role in filament stabilization, bundling and bending as well as interactions with other septins and in silico modeling suggest the addition of 9 amino acids (aa) associated with the SEPTIN6 c.1282T>C p.428Glnext*9 mutation would alter function by interfering with SEPTIN6 protein interactions. Based on our initial publication, a second patient with severe neutropenia has since been identified in Seattle with a distinct mutation in the same codon (SEPTIN6 c.1282T>A) (Mohamad, Allensbach, Williams, accepted for presentation, ASH 2022). While the aa substitution is different, modeling predicts that SEPTIN6 variants adopt the same structure. Both identified patients had a high degree of myeloid tetraploidy in the marrow and were refractory to G-CSF.
(请保持言语,不要PDF)
标题:Septin6组在鼠和人类造血中的作用
1 R01 DK137172-01
SEPTIS是高度保守的GTPase蛋白,可调节各种细胞功能,包括细胞因子,极性,细胞周期,囊泡运输,胞吞作用以及扩散屏障的创造。我们最近在septin6基因的C-末端(Septin6 C.1282T> p p.428glnext*9)鉴定出具有严重中性粒细胞减少症(Renella,AJH 2022)的非合成新生儿(Renella,AJH 2022)。将种系突变编辑为正常的雄性CD34+造血干细胞和祖细胞(HSC/P)临床综合征的近角型关键病理特征,包括大型的多核核和髓样祖细胞降低的体外(初步数据)。已经提出了C末端在细丝稳定,捆绑和弯曲以及与其他septins的相互作用中发挥关键作用,并在硅胶建模中互动表明,与SEPTIN6 C.1282T> C P.428GLNEXT*9相关的9个氨基酸(AA)添加了9个氨基酸(AA)*9突变会通过与Septin6蛋白质相互作用而改变功能。根据我们的首次出版物,此后在西雅图发现了第二名患有严重中性粒细胞减少症的患者,在同一密码子(Septin6 C.1282T> a)中有明显的突变(Mohamad,Allensbach,Williams,Williams,接受演示,Ash 2022)。尽管AA替代是不同的,但建模预测Septin6变体采用相同的结构。两者都确定的患者在骨髓中具有高度的髓样四倍体,对G-CSF具有难治性。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DAVID A WILLIAMS其他文献
DAVID A WILLIAMS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DAVID A WILLIAMS', 18)}}的其他基金
Gene therapy targeting BCL11A to induce fetal hemoglobin and reduce sickle hemoglobin in patients with Sickle Cell Disease
靶向 BCL11A 的基因疗法可诱导胎儿血红蛋白并降低镰状细胞病患者的镰状血红蛋白
- 批准号:
10083551 - 财政年份:2020
- 资助金额:
$ 35.4万 - 项目类别:
Gene therapy targeting BCL11A to induce fetal hemoglobin and reduce sickle hemoglobin in patients with Sickle Cell Disease
靶向 BCL11A 的基因疗法可诱导胎儿血红蛋白并降低镰状细胞病患者的镰状血红蛋白
- 批准号:
10179447 - 财政年份:2017
- 资助金额:
$ 35.4万 - 项目类别:
Gene therapy targeting BCL11A to induce fetal hemoglobin and reduce sickle hemoglobin in patients with Sickle Cell Disease
靶向 BCL11A 的基因疗法可诱导胎儿血红蛋白并降低镰状细胞病患者的镰状血红蛋白
- 批准号:
9363943 - 财政年份:2017
- 资助金额:
$ 35.4万 - 项目类别:
Gene Therapy for SCID-X1 with Low Dose Busulfan and a SIN-lentiviral Vector
使用低剂量白消安和 SIN 慢病毒载体对 SCID-X1 进行基因治疗
- 批准号:
10827632 - 财政年份:2016
- 资助金额:
$ 35.4万 - 项目类别:
Development of novel selective Rac inhibitors for refractory leukemias
开发治疗难治性白血病的新型选择性 Rac 抑制剂
- 批准号:
9176356 - 财政年份:2016
- 资助金额:
$ 35.4万 - 项目类别:
Gene therapy for SCID-X1 with low dose busulfan and a SIN-lentiviral vector
使用低剂量白消安和 SIN 慢病毒载体对 SCID-X1 进行基因治疗
- 批准号:
10207386 - 财政年份:2016
- 资助金额:
$ 35.4万 - 项目类别:
相似国自然基金
来源和老化过程对大气棕碳光吸收特性及环境气候效应影响的模型研究
- 批准号:42377093
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
内源DOM介导下微塑料的老化过程及对植物的影响机制
- 批准号:42377233
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
老化过程对沙尘辐射效应和反馈机制的影响研究
- 批准号:42375107
- 批准年份:2023
- 资助金额:50.00 万元
- 项目类别:面上项目
生物炭原位修复底泥PAHs的老化特征与影响机制
- 批准号:42307107
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
河口潮滩中轮胎磨损颗粒的光老化特征及对沉积物氮素转化的影响与机制
- 批准号:42307479
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Optimizing integration of veterinary clinical research findings with human health systems to improve strategies for early detection and intervention
优化兽医临床研究结果与人类健康系统的整合,以改进早期检测和干预策略
- 批准号:
10764456 - 财政年份:2023
- 资助金额:
$ 35.4万 - 项目类别:
Robust Precision Mapping of Cortical and Subcortical Brain Metabolic Signatures in AD
AD 中大脑皮层和皮层下代谢特征的稳健精确绘图
- 批准号:
10746348 - 财政年份:2023
- 资助金额:
$ 35.4万 - 项目类别:
The role of oligodendrocyte precursor cells in circuit remodeling in the mature brain
少突胶质细胞前体细胞在成熟脑回路重塑中的作用
- 批准号:
10750508 - 财政年份:2023
- 资助金额:
$ 35.4万 - 项目类别: